ArticleJACC. Case reports2025
Cardiogenic Shock Management: Single-Center Experience With a Percutaneous Left Ventricular Assist Device Escalation Strategy.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mortality rates for cardiogenic shock (CS) remain high, but the development of percutaneous left ventricular assist devices and the adoption of a shock-team approach, which emphasizes early use of mechanical circulatory support (MCS) devices and hemodynamic monitoring, has been shown to improve outcomes. The introduction of the Impella CP and Impella 5.5 has expanded options for left ventricular temporary MCS. This case series highlights our experience managing patients with CS using a shock protocol escalation strategy from Impella CP to Impella 5.5. Notably, all cases reflect the decision-making process of transitioning to a different MCS modality quickly based on real-time hemodynamic data. We believe our shock protocol can be easily adapted by most US hospitals with cardiac catheterization laboratories and can be replicated in most settings with minimal adjustments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.